The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Abstract
Alzheimer's disease (AD) is the most common cause of progressive intellectual failure in aged humans. AD brains contain numerous amyloid plaques surrounded by dystrophic neurites, and show profound synaptic loss, neurofibrillary tangle formation and gliosis. The amyloid plaques are composed of amyloid beta-peptide (A beta), a 40-42-amino-acid fragment of the beta-amyloid precursor protein (APP). A primary pathogenic role for APP/A beta is suggested by missense mutations in APP that are tightly linked to autosomal dominant forms of AD. A major obstacle to elucidating and treating AD has been the lack of an animal model. Animals transgenic for APP have previously failed to show extensive AD-type neuropathology, but we now report the production of transgenic mice that express high levels of human mutant APP (with valine at residue 717 substituted by phenylalanine) and which progressively develop many of the pathological hallmarks of AD, including numerous extracellular thioflavin S-positive A beta deposits, neuritic plaques, synaptic loss, astrocytosis and microgliosis. These mice support a primary role for APP/A beta in the genesis of AD and could provide a preclinical model for testing therapeutic drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mouse models that overexpress amyloid precursor protein (APP) develop plaques remarkably similar to those observed in AD but do not recapitulate neurofibrillary pathology or widespread neuronal loss (Games et al., 1995;Hsiao et al., 1996;Irizarry et al., 1997a;Urbanc et al., 2002), allowing interpretation of results in the context of amyloid-related pathologies.”
From Dendritic Spine Abnormalities in Amyloid Precursor Protein Transgenic Mice Demonstrated by Gene Transfer and Intravital Multiphoton Microscopy (2005) · cites this paper as Games et al., 1995
In the citing paper
“Similar to AD, APP transgenic mouse models have elevated inflammation markers and gliosis associated with amyloid deposits (Games et al., 1995; Hsiao et al., 1996; Sturchler-Pierrat et al., 1997).”
From Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation (2006) · cites this paper as Games et al., 1995
In the citing paper
“The first successful mouse models reproducing Aβ pathologies overexpressed human APP with either a single Swedish [25, 26] or Indiana [27] mutation.”
From Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer’s disease (2019) · cites this paper as [27]
In the citing paper
“The hAPP tg line J9 selected for this study expresses an alternatively spliced minigene, hA PP, bearing the amyloidogenic V717F and K670M / N671L mutations that have been linked to familial AD (Games et al., 1995).”
From Increased Extracellular Amyloid Deposition and Neurodegeneration in Human Amyloid Precursor Protein Transgenic Mice Deficient in Receptor-Associated Protein (2002) · cites this paper as Games et al., 1995
In the citing paper
“The J9 model utilizes a mini-APP gene that can produce all three isoforms of APP: APP695, APP751 and APP770 [41].”
From Receptor-Associated Protein (RAP) Plays a Central Role in Modulating Aβ Deposition in APP/PS1 Transgenic Mice (2008) · cites this paper as [41]
In the citing paper
“These genetic findings led to several transgenic mouse models that successfully recapitulated Aβ plaque formation, increasing support for the hypothesis (Table 1) [23–29].”
From Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau (2021) · cites this paper as [25]
Citations
Cites
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
Manipulating the mouse embryo: A laboratory manual
Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460
Manipulating the mouse embryo: A laboratory manual
Johnson, M. (1986) · Trends in Genetics · doi:10.1016/0168-9525(86)90275-1 · Cited by 2,259
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
Self-citationQuantitation of mRNA by the polymerase chain reaction.
Wang, A. M., DOYLE, M. V., & Mark, D. F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9717 · Cited by 1,630
Suzuki, N., Cheung, T. T., Cai, X.-D., Odaka, A., Otvos, L., Eckman, C., Golde, T. E., & Younkin, S. G. (1994) · Science · doi:10.1126/science.8191290 · Cited by 1,471
A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease
Murrell, J. R., Farlow, M. R., Ghetti, B. F., & Benson, M. D. (1991) · Science · doi:10.1126/science.1925564 · Cited by 1,142
Normal and Abnormal Biology of the Beta-Amyloid Precursor Protein
Selkoe, D. J. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.002421 · Cited by 834
Roher, A. E., Lowenson, J. D., Clarke, S., Wolkow, C., Wang, R., Cotter, R. J., Reardon, I. M., Zürcher-Neely, H. A., Heinrikson, R. L., & Ball, M. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53661-9 · Cited by 799
Sasahara, M., Fries, J. W. U., Raines, E. W., Gown, A. M., Westrum, L. E., Frosch, M. P., Bonthron, D. T., Ross, R., & Collins, T. (1991) · Cell · doi:10.1016/0092-8674(91)90223-l · Cited by 411
Formation of β-amyloid protein deposits in brains of transgenic mice
Quon, D. H., Wang, Y., Catalano, R., Scardina, J. M., Murakami, K., & Cordell, B. (1991) · Nature · doi:10.1038/352239a0 · Cited by 406
Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice
Lamb, B. T., Sisodia, S. S., Lawler, A. M., Slunt, H. H., Kitt, C. A., Kearns, W. G., Pearson, P. L., Price, D. L., & Gearhart, J. D. (1993) · Nature Genetics · doi:10.1038/ng0993-22 · Cited by 311
Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease.
Masliah, E., Terry, R. D., Alford, M. F., DeTeresa, R. M., & Hansen, L. A. (1991) · PubMed Central · Cited by 296
Self-citationOltersdorf, T., Ward, P. J., Henriksson, T., Beattie, E. C., Neve, R. L., Lieberburg, I. M., & Fritz, L. C. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39590-0 · Cited by 281
Self-citationSynaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice
Mucke, L., Masliah, E., Johnson, W. B., Ruppe, M. D., Alford, M. F., Rockenstein, E. M., Forss‐Petter, S., Pietropaolo, M., Mallory, M. E., & Abraham, C. R. (1994) · Brain Research · doi:10.1016/0006-8993(94)90767-6 · Cited by 270
Self-citationMaggio, J. E., Stimson, E. R., Ghilardi, J. R., Allen, C. J., Dahl, C. E., Whitcomb, D. C., Vigna, S. R., Vinters, H. V., Labenski, M. E., & Mantyh, P. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5462 · Cited by 195
Immunoelectron microscopic study of synaptic pathology in Alzheimer's disease
Masliah, E., Hansen, L. A., Albright, T., Mallory, M. E., & Terry, R. D. (1991) · Acta Neuropathologica · doi:10.1007/bf00293464 · Cited by 175
Self-citationArai, H., Lee, V. M., Otvos, L. P., Greenberg, B., Lowery, D. E., Sharma, S., Schmidt, M. L., & Trojanowski, J. Q. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2249 · Cited by 155
Neurofibrillary Tangles and Senile Plaques in Aged Bears
Cork, L. C., Powers, R. E., Selkoe, D. J., Davies, P., Geyer, J. J., & Price, D. L. (1988) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198811000-00006 · Cited by 145
Tamaoka, A., Kalaria, R. N., Lieberburg, I. M., & Selkoe, D. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.4.1345 · Cited by 143
Self-citationLack of alzheimer pathology after β-amyloid protein injections in rat brain
Games, D., Khan, K., Soriano, F., Keim, P. S., Davis, D. L., Bryant, K., & Lieberburg, I. M. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90057-5 · Cited by 127
Self-citationTransgenic mouse brain histopathology resembles early Alzheimer's disease
Higgins, L. S., Holtzman, D. M., Rabin, J., Mobley, W. C., & Cordell, B. (1994) · Annals of Neurology · doi:10.1002/ana.410350514 · Cited by 112
Re-Evaluation of the Structural Organization of Neuritic Plaques in Alzheimerʼs Disease
MASLIAH, E., MALLORY, M., DEERINCK, T., DETERESA, R., LAMONT, S., MILLER, A., TERRY, R. D., CARRAGHER, B., & ELLISMAN, M. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199311000-00009 · Cited by 105
Self-citationDickson, D. W., Wertkin, A. M., Mattiace, L. A., Fier, E., Kress, Y., Davies, P., & Yen, S. H. (1990) · Acta Neuropathologica · doi:10.1007/bf00296107 · Cited by 102
Spatial resolution of the primary beta-amyloidogenic process induced in postischemic hippocampus.
Saido, T. C., Yokota, M., Maruyama, K., Yamao‐Harigaya, W., Tani, E., Ihara, Y., & Kawashima, S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36599-7 · Cited by 80
Pearson, B. E., & Choi, T. K. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10578 · Cited by 77
Sandhu, F. A., Salim, M., & Zain, S. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54637-8 · Cited by 68
Hardy, J. (1994) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30343-4 · Cited by 20
Flagged first, then by citations
Research works printed but not linked: 4
- Mann, D. M. A. et al. Neurodegeneration 1, 201–215 (1992).
- McConlogue, L. et al. Neurobiol. Aging 15, S12 (1994).
- Masliah, E. et al. Am. J. Path. 138, 235–246 (1991).
- Chomazynski, P. & Sacchi, N. Analyt. Biochem. 162, 156–159 (1987).
Cited by
Sorted by citations
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530
“Similar to AD, APP transgenic mouse models have elevated inflammation markers and gliosis associated with amyloid deposits (Games et al., 1995; Hsiao et al., 1996; Sturchler-Pierrat et al., 1997).”
Background
Metadata
- Authors
- Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., Guido, T., Hagopian, S., Johnson-Wood, K., Khan, K., Lee, M., Leibowitz, P., Lieberburg, I., Little, S., Masliah, E., McConlogue, L., Montoya-Zavala, M., Mucke, L., Paganini, L., Penniman, E., Power, M., Schenk, D., Seubert, P., Snyder, B., Soriano, F., Tan, H., Vitale, J., Wadsworth, S., Wolozin, B., & Zhao, J.
- Affiliations
- Worcester Polytechnic Institute (US)
- University of Massachusetts Chan Medical School (US)
- Eli Lilly (United States) (US)
- Boston Children's Hospital (US)
- University of California San Diego (US)
- Scripps Research Institute (US)
- ORCID
- Venue
- Nature
- Published
- 1995-02
- Volume
- 373
- Issue
- 6514
- Pages
- 523-527
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2126800086
- Cited by
- 2,516
- References
- 28
- Citations by year
- 2026: 17 · 2025: 34 · 2024: 55 · 2023: 38 · 2022: 42 · 2021: 52 · 2020: 55 · 2019: 42 · 2018: 35 · 2017: 54 · 2016: 69 · 2015: 64 · 2014: 58 · 2013: 75 · 2012: 73
- FWCI
- 101.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amyloid precursor protein, transgenic mice, amyloid-beta, amyloid plaques, neuritic plaques, synaptic loss, astrocyte activation, microglial activation, animal models of Alzheimer's disease, thioflavin S staining
- MeSH terms
- Alzheimer Disease, Animals, Base Sequence, Brain, Humans, Immunoenzyme Techniques, Mice, Transgenic, Molecular Sequence Data, Mutation, Platelet-Derived Growth Factor, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, DNA Primers, Microscopy, Confocal, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
